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The search for new therapeutic agents has been a constant for the treatment of diseases such as leish-
maniasis and Chagas disease. Most drugs used have side effects, justifying the need to evaluate the cyto-
toxicity of the tested products for candidates to new drugs. In this study, the bioactivity of Lygodium
venustum, a cosmopolitan fern of Lygodiaceae, was assessed about their leishmanicidal and trypanocidal
potential. The better activity was observed using methanol fraction, with inhibition percentage of 63%
and 68% for promastigotes and epimastigotes, respectively, at a concentration of 500 lg/mL. The ethyl
acetate and methanol fractions demonstrated a higher cytotoxic potential. This was the ﬁrst report of
leishmanicidal, trypanocidal and cytotoxic activities to L. venustum.
 2013 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
The Leishmaniasis is a polymorphic group of diseases caused by
protozoan parasites of the genus Leishmania (Kinetoplastida, Try-
panosomatidae). The parasite is transmitted by female sandﬂiese Química Biológica, Univer-
, Antonio Luis 1161, Pimenta
Coutinho).
evier OA license.of the genus Phlebotomus in the Old World and Lutzomyia in the
New World (Berman, 1998). The disease has diverse clinical pre-
sentations and can affect the skin, mucous membranes and inter-
nal organs. The parasite Leishmania brasiliensis is one of those
responsible for the cutaneous form (CL) and mucocutaneous
(LMC) of the disease, being understood as American Cutaneous
Leishmaniasis (Genaro and Michalick, 2005; Genaro and Reis,
2005). For the treatment of Leishmaniasis are used pentavalent
antimonials, amphotericin B, pentamidine and miltefosine, all
demonstrating high toxicity, high cost and problems during the
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et al., 2003; Croft and Coombs, 2003).
Chagas disease or American trypanosomiasis is a disease caused
by Trypanosoma cruzi, transmitted by haematophagous insects
from the genus Triatoma, (Reduviidae) (Lana and Tafuri, 2005). Sev-
eral tests were performed seeking a therapeutic solution against
this infectious disease. Benzonidazole and nifurtimox are the main
compounds used as antiparasitic drugs for American trypanosomi-
asis, but these drugs are not consistently effective and have serious
side effects, including cardiac and renal toxicity (Veloso et al.,
2001; Ruiz et al., 2004).
Due the difﬁculty to discover drugs effective in the therapy and
non toxic to humans, natural products have been tested. Many spe-
cies of plants have been investigated for their antileishmanial and
trypanocidal activities (Mesquita et al., 2005; Coro et al., 2005).
Isolated semi-synthetic or synthetic compounds are also studied
to discover new therapeutic agents against these diseases (Roldós
et al., 2008; Saraiva et al., 2007; Moran, 1995).
Lygodium venustum (Lygodiaceae) is a fern with worldwide dis-
tribution and lianescent habit (Klaus, 2006). This fern is used as a
bioindicator of environmental degradation and as a remedy in
the folk medicine by South American populations (Duke, 2008;
Argueta et al., 1994; Brasileiro et al., 2006).
The objective of this study to was evaluate, through in vitro as-
says, the trypanocidal and leishmanicidal and cytotoxic activity of
ethanol extract and dichloromethane, ethyl acetate and methanol
fractions of leaves from L. venustum.2. Material and methods
2.1. Plant material
Leaves of L. venustum were collected in may 2010 in the city of
Crato, Ceará State, Brazil. The plant material was identiﬁed by Dr.
Antonio Álamo Feitosa Saraiva, and voucher specimen have been
deposited with the identiﬁcation number 5569 HCDAL at the Her-
barium Caririense Dárdano de Andrade-Lima, of the University of
the Region of Cariri – URCA.
2.2. Preparation of ethanol extract (EELV) and dichloromethane, ethyl-
acetate and methanol fractions (DFLV, EAFLV, MFLV) of L. venustum
Leaves were collected and 211.18 g were weightened, dried and
keeped at room temperature. This material was powdered and ex-
tracted by maceration using 1L of 95% ethanol solvent at room
temperature. The mixture was allowed to stand for 72 h at room
temperature. The extract was ﬁltered and concentrated under vac-
uum in rotary evaporator at 60 C and 760 mm/Hg temperature
and pressure, respectively (Buckner et al., 1996), obtaining
12.42 g of ethanol extract. Fractionation was performed using the
ethanol extract, resulting in the fractions used in the tests (dichlo-
romethane, ethyl acetate and methanol to yield 0.39 g, 0.52 g and
3 g, respectively). The extract and fractions were diluted to
0.01 mg each using DMSO before the assays.
2.3. Cell lines used
For in vitro studies of T. cruzi, the clone CL-B5 was used (Le
Senne et al., 2002). Parasites were stably transfected with the Esch-
erichia coli b-galactosidase gene (lacZ), were provided by Dr. F.
Buckner through Instituto Conmemorativo Gorgas (Panama).
Epimastigotes were grown at 28 C in liver infusion tryptose broth
(Difco, Detroit, MI) with 10% fetal bovine serum (FBS) (Gibco, Carls-
bad, CA), penicillin (Ern, S.A., Barcelona, Spain) and streptomycin
(Reig Jofré S.A., Barcelona, Spain), as described previously (Roldóset al., 2008), and harvested during the exponential growth phase.
Culture of L. brasiliensis was obtained from the Instituto de
Investigaciones en Ciencias de la Salud, Asunción, Paraguay - IICS.
The maintenance of strain, the form of cultivation and isolation
shape promatigota followed the procedures described by Roldós
et al. (2008). The inhibition assays of promastigotes were per-
formed using the strain of L. braziliensis (MHOM/BR/75/M2903),
grown at 22 C in Schneider’s Drosophila medium supplemented
with 20% FBS. For the cytotoxic assays, was used the ﬁbroblast cell
line NCTC929 grown in Minimal Essential Medium (Sigma). The
culture medium was supplemented with heat-inactivated FBS
(10%), penicillin G (100 U/ml) and streptomycin (100 lg/mL). Cul-
tures were maintained at 37 C in humid atmosphere with 5% CO2.
The viability of these strains was assessed according to Roldós et al.
(2008), through the use of resazurin as a colorimetric method.
2.4. Reagents
Resazurin sodium salt was obtained from Sigma–Aldrich (St.
Louis, MO) and stored at 4 C protected from light. A solution of
resazurin was prepared in 1% phosphate buffer, pH 7, and ﬁlter
sterilized prior to use. Chlorophenol red-b-D-galactopyranoside
(CPRG; Roche, Indianapolis, IN) was dissolved in 0.9% Triton X-
100 (pH 7.4). Penicillin G (Ern, S.A., Barcelona, Spain), streptomycin
(Reig Jofré S.A., Barcelona, Spain) and dimethylsulfate were also
used.
2.5. In vitro epimastigote susceptibility assay
The screening assay was performed in 96-well microplates with
cultures that had not reached the stationary phase (Vega et al.,
2005). Brieﬂy, epimastigotes were seeded at 1  105 mL1 in
200 lL of liver tryptose broth medium. The plates were then incu-
bated with the drugs (0.1–50 lg/mL) at 28 C for 72 h, at which
time 50 lL of CPRG solution was added to give a ﬁnal concentra-
tion of 200 lM. The plates were incubated at 37 C for an addi-
tional 6 h and were then read at 595 nm. Each experiment was
performed twice and independently, each concentration was
tested in triplicate in each experiment. The efﬁcacy of each com-
pound was estimated by calculating the anti epimastigotes percen-
tual (AE%).
2.6. In vitro leishmanicidal assay
The assay was performed using a modiﬁcation of a previous
method. Cultures of promastigotes of L. brasiliensis were grown
to a concentration of 106 cells/mL and then transferred to the test.
The compounds were dissolved in DMSO to the concentrations to
be tested and were transferred to microplates. Each test was per-
formed in triplicate. The activity of compounds was evaluated after
72 h by direct counting of cells after serial dilutions and compared
with an untreated control.
2.7. Cytotoxic assays
NCTC929 ﬁbroblasts were plated in 96-well microplates at a ﬁ-
nal concentration of 3  104 cells/well. The cells were grown at
37 C in an atmosphere of 5% CO2. After that, the culture medium
was removed and the compounds were added to 200 lL, and per-
formed a new culture for 24 h. After this incubation, 20 lL of a
2 mM solution of resazurin was added to each well. The plates
were incubated for 3 h and the reduction of resazurin was mea-
sured using dual absorbance at wavelengths of 490 and 595 nm.
The value of the control (blank) was subtracted. Each concentra-
tion was tested in triplicate.
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All chemical were of analytical grade. Methanol, acetic acid, gal-
lic acid, chlorogenic acid and caffeic acid purchased from Merck
(Darmstadt, Germany). Quercetine, rutine and kaempferol were ac-
quired from Sigma Chemical Co. (St. Louis, MO, USA). High perfor-
mance liquid chromatography (HPLC-DAD) was performed with
the HPLC system (Shimadzu, Kyoto, Japan), Prominence Auto Sam-
pler (SIL-20A), equipped with Shimadzu LC-20AT reciprocating
pumps connected to the degasser DGU 20A5 with integrator CBM
20A, UV–VIS detector DAD (diode) SPD-M20A and Software LC
solution 1.22 SP1.2.9. Quantiﬁcation of compounds by HPLC-DAD
Reverse phase chromatographic analyses were carried out un-
der gradient conditions using C18 column (4.6  250 mm) packed
with 5 lm diameter particles; the mobile phase was water con-
taining 2% acetic acid (A) and methanol (B), and the composition
gradient was: 5% of B until 2 min and changed to obtain 25%,
40%, 50%, 60%, 70% and 100% B at 10, 20, 30, 40, 50 and 80 min,
respectively, following the method described by Laghari et al.
(2011) with slight modiﬁcations. The samples of the fern were ana-
lyzed, dissolved in ethanol at a concentration of 3 mg/mL. The
presence of six phenolics compounds was investigated, namely,
gallic, chlorogenic and caffeic acids and the ﬂavonoids quercetin,
rutin and kaempferol. Identiﬁcation of these compounds was per-
formed by comparing their retention time and UV absorption spec-
trum with those of the commercial standards. The ﬂow rate was
0.6 mL/min, injection volume 40 lL and the wavelength were
254 nm for gallic acid, 325 nm for caffeic and chlorogenic acids,
and 365 nm for quercetine, rutine and kaempferol. All the samples
and mobile phase were ﬁltered through 0.45 lm membrane ﬁlter
(Millipore) and then degassed by ultrasonic bath prior to use. Stock
solutions of standards references were prepared in the HPLC mo-
bile phase at a concentration range of 0.020–0.200 mg/mL for
kaempferol, quercetin and rutin; and 0.050–0.250 mg/mL for gallic,
caffeic and chlorogenic acids. The chromatography peaks were
conﬁrmed by comparing its retention time with those of reference
standards and by DAD spectra (200 to 400 nm). Calibration curve
for caffeic acid: Y = 10523x + 1478.8 (r = 0.9999); caffeic acid:
Y = 12765x + 1381.7 (r = 0.9995); rutin: Y = 12691  1165.0
(r = 0.9998); quercetin: Y = 13495x  1092.6 (r = 0.9999) and
kaempferol: Y = 15692x  1218.1 (r = 0.9997). All chromatography
operations were carried out at ambient temperature and in
triplicate.Fig. 1. Representative high performance liquid chromatography proﬁle of ethyl
acetate fraction (a), dichloromethane fraction (b) and methanol fraction (c)
detection UV was at 327 nm. Gallic acid (peak 1), chlorogenic acid (peak 2), caffeic
acid (peak 3), rutin (peak 4), quercetin (peak 5) and kaempferol (peak 6).3. Results and discussion
Several researches use in vitro and in vivo biological assays
against parasites from the Trypanosomatidae family in mammal
cell lines or in animal models. According Castilhos (2008), studies
against Leishmania spp. are focused in the extracellular form of this
parasite, called promastigote form due the facility to keep in vitro
cultures and the possibility of not use other cell lines as macro-
phages. All these assays are preliminary, but very importance to
determine the antiparasitic potential of drugs and natural products
to be tested using now in vivo assays. The same reason explains the
use of epimastigote forms of T. cruzi. This cell form is present inside
the macrophage of the vertebrate host (Michalick, 2005).
Cytotoxic in vitro assay is the ﬁrst test to evaluate the biocom-
patibility of any material for use in biomedical devices (Interna-
tional Standard, 1992). In most cases, the results are not
extrapolated directly to the animals, because if a product causesdamage to cells in vitro, may also affect animals exposed (Carvalho,
1996).
The most widely used parameter to assess cytotoxic activity is
the cell viability, which can be detected by the use of dyes as neu-
tral red, which allows the distinction between living cells and dam-
aged or dead (Ciapetti et al., 1996).
Different products have been tested to evaluate the cytotoxic
potential, allowing the possibility of discovering new drug candi-
dates, whose side effects are lower. Among plants, the angiosperms
are the most studied. Different cells can be used in these assays, as
astrocytes, macrophages and human or murine ﬁbroblasts, or brine
Table 1
In vitro activity of fractions of ethanol extract of leaves of L. venustum against L.
brasiliensis and T. cruzi and cytotoxicity.
Fractions Concentrations
(lg/mL)
(%C) Antiparasitic activity
(%EA) (%PA)
Dichloromethane 500 0 34 6
100 0 0 0
Ethylacetate 500 67 45 0
100 30 45 0
Methanol 500 53 63 68
100 0 28 31
%C: percentage of killing ﬁbroblasts; %EA: percentage of killing epimastigotes of T.
cruzi; %PA: percentage of killing promastigotes of L. braziliensis.
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2006; Hughes et al., 2006; Lima et al., 2009).
A qualitative chemical screening using the methodology of Ma-
tos (1997) showed that the ethanol extract of L. venustum presents
in its composition of secondary metabolites (data not shown), such
as ﬂobabenic tannins, ﬂavones, xanthones, chalcones, ﬂavonoids,
alkaloids and ﬂavonones and some of these compounds have al-
ready demonstrated antiparasitic potential (Torres-Santos et al.,
1999; Kam et al., 1999; Leite et al., 2010).
HPLC ﬁngerprinting of L. venustum fractions revealed the pres-
ence of the gallic acid (tR = 17.83 min; peak 1), chlorogenic acid
(tR = 28.14 min; peak 2), caffeic acid (tR = 34.09 min; peak 3), rutin
(tR = 42.11 min; peak 4), quercetin (tR = 49.78 min; peak 5) and
kaempferol (tR = 58.96 min; peak 6) (Fig. 1). The HPLC analysis re-
vealed that ﬂavonoids (quercetin, rutin and kaempferol) and phen-
olics acids (gallic, chlorogenic and caffeic acids) are present in the
fern (Table 2).
Amongst the evaluated fractions, the dichloromethane fraction
had not demonstrated antiparasitic activity against both parasites
at 100 lg/mL and a low activity against T. cruzi at 500 lg/mL. The
main phenolic compound present in this fraction is the kaempferol
(0.39%), indicating a low level of phenolic compounds. Kaempferol
and its acethylated derived had demonstrated an in vitro anti-Try-
panosoma activity using mammal cell lines, affecting the metacy-
clic forms of this parasite, the replications and the
transformation to trypomastigote forms (Boutaleb-Charki et al.,
2011). However, this effect was observed when the kaempferol
was assayed alone. When assayed mixed with other phytocom-
pounds, its activity can be inhibited or not, being necessary a high
concentrations to be observed the same effect. Te cytotoxic assay
indicates that the phytocompounds extracted using non-polar sol-
vents demonstrated a low toxicity against ﬁbroblasts (Table 1).
The ethylacetate fraction is well known about the efﬁciency to
extract ﬂavonoids (Simões et al., 2010). This fraction had not any
effect against L. brasiliensis in the assayed concentrations, but
was observed 45% of inhibition against the epimastigote form.
These results suggest that epimastigote form is more sensitive than
the amastigote form to the phenolic compounds in this fraction.
Besides, according Turnock and Ferguson (2007), the glycoconju-Table 2
Phenolics and ﬂavonoids composition of Lygodium venustum fractions.
Natural products Gallic acid Clorogenic acid Caffeic
EAFLV mg/g 3.07 ± 0.01a 6.65 ± 0.03b 13.02 ±
EAFLV% 0.30 0.66 1.30
DFLV mg/g 0.62 ± 0.03a 0.57 ± 0.01b 0.71 ± 0
DFLV% 0.06 0.05 0.07
MFLV mg/g 2.02 ± 0.03a 11.39 ± 0.02b 3.91 ± 0
MFLV% 0.20 1.13 0.39
Results are expressed as mean ± standard deviations (SD) of three determinations. Averag
fraction of L. venustum; DFLV: dichloromethane fraction of L. venustum; MFLV: methanogates in the cell surface of the trypanosomatidae parasites are in-
volved in the surveillance, virulence and infectivity of the
parasites on yours vectors and mammal hosts. These authors iden-
tiﬁed monosaccharides present also in T. cruzy and L. major (GDP-
a-D-mannose, UDP-a-D-N-acetylglucosamine, UDP-a-D-glucose,
UDP-a-galactopyranose, GDP-ß-L-fucose and UDP-a-D-galactofura-
nose), present only in T. cruzi (UDP-ß-L-rhamnopyranose, UDP-a-D-
xylose and UDP-a-D-glucuronic acid) and GPD-a-D-arabinopyra-
nose, present only in L. major. The presence or absence of these
compounds in the parasites cells can determine the selective up-
take of determined phytocompounds.
The main compound of the ethylacetate fraction of L. venustum
is quercetine (5.98%). Several reports indicate that this ﬂavonoid
present an remarkable antiparasite activity against Leishmania
donovani (EC50 1 mg/mL), but not against T. cruzi (Tasdemir et al.,
2006). In this study, the activity of quercetine apparently was
antagonized by other phytocompounds of this fraction. However,
was observed an expressive cytotoxic activity, killing 67% of ﬁbro-
blasts at 500 lg/mL (Table 1).
The best results against the promastigote and epimastigote
forms of L. brasiliensis and T. cruzi respectively were observed in
the assays with the methanol fraction, killing 68% and 63% of the
parasites cell forms at 500 lg/mL (Table 1). The main phenolic
compound detected in this fraction was the Chlorogenic acid
(1.13%). A moderate leishmanicidal activity of the chologenic acid
was detected in the study of Kirmizibekmez et al. (2004), being
similar with our results. By other side, the antiparasitic activity
of this fraction can be attributed to the other phytocompounds
due the fact of using a polar solvent as methanol, the extraction
of heterosides and alkaloids can be enhanced (Simões et al.,
2010). Other studies had demonstrated that these other secondary
metabolites present a relevant antiparasitary activity against Leish-
mania and Tripanosoma (Bravo et al., 2001; Batista et al., 2007;
Fournet et al., 2007). The cytotoxic activity demonstrated by this
fraction was considered moderate (53%).
The analysis of biochemical factors involved in Leishmania- and
Trypanosoma-host interactions shows that these parasites have
metabolic pathways similar to those found in host cells. This con-
dition makes the treatment of the diseases caused by these proto-
zoa is difﬁcult (Soares-Bezerra et al., 2004). So, the research of new
drugs with antiparasitic activity and low toxicity is very important,
mainly to be used as therapeutic alternatives against these ne-
glected diseases.4. Conclusion
Until this study, no species of the family Lygodiaceae had been
tested against parasites of the genus Leishmania and Trypanosoma,
as well as never before had their cytotoxic effects observed. So, this
is the ﬁrst report on bioactivity and cytotoxicity against parasites
by a species of this pteridophytes group. This fact indicates the
necessity of study these plants as a future source of natural prod-
ucts with antiparasitic and other activities.acid Rutin Quercetin Kaempferol
0.04c 10.74 ± 0.02d 59.83 ± 0.01e 11.09 ± 0.01 cd
1.07 5.98 1.10
.01ab – 0.80 ± 0.02b 3.93 ± 0.01c
– 0.08 0.39
.03c 6.16 ± 0.01c 1.88 ± 0.01a –
0.61 0.18 –
es followed by different letters differ by Tukey test at p < 0.005. EAFLV: ethyl acetate
l fraction of L. venustum.
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